Endeavor

How Can We Stop Tumors from Shutting Down our Immune Response to Cancer?

Moffitt researchers create revolutionary Images of LAG3 receptors

Phase 2 Bladder Cancer Trial Shows Promising Results

Updated data were presented at the 2022 SITC Annual Meeting

Using AI to Dictate Treatment for Non-Small Cell Lung Cancer

Data presented at the Society for Immunotherapy of Cancer shows AI can perform biomarker tests

Cellular Therapy May Be Viable Option for Advanced Melanoma Patients

Nearly one-third of patients respond to a single infusion of tumor infiltrating lymphocytes

New Immunotherapy Could Be on the Horizon for Ovarian Cancer

Understanding tertiary lymphoid structures could unlock new treatments for a variety of cancers

Can Higher Doses of Radiation Be Effective for Soft Tissue Sarcoma?

Acute toxicity can present challenges like skin redness and infections

DRIVE Study Offers New Treatment Options for Vulvar Cancer

Data shows radiation therapy as effective first line treatment

Expanding Targets for Cell Therapy

Thanks to the infrastructure in place for blood cancers, Moffitt is ready to expand CAR T-cell therapy to solid tumors

Combining Targeted Radiotherapy with Immunotherapy May Improve Outcomes for Cervical Cancer Patients

Interim results from phase 2 clinical trial reveal responses to combination therapy